Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 1:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1969–1992 of 2,539 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parasomnia Clear all

Conditions: Obstructive Sleep Apnea (OSA), OSA, Obstructive Sleep Apnea
Interventions: Automated manual lymphatic drainage therapy (AMLDT) device; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 50 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Stress, Psychological, Sleep Disturbance, Burnout, Caregiver, Posttraumatic Stress Disorder, Anxiety, Depression
Interventions: Nature Only, Nature+Mindfulness; Behavioral
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Restless Legs Syndrome
Interventions: Ropinirole Extended Release (XR); Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 380 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 60
States / cities: Alabaster, Alabama • Jasper, Alabama • Mesa, Arizona + 55 more

Conditions: Obstructive Sleep Apnea, Hypertension
Interventions: AD113, Atomoxetine; Drug
Lead sponsor: Apnimed; Industry
Eligibility: 25 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: Towson, Maryland • Cincinnati, Ohio • Columbia, South Carolina

Conditions: Transient Insomnia
Interventions: SM-1, Active Comparator; Drug
Lead sponsor: Sequential Medicine Ltd; Industry
Eligibility: 25 Years to 55 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Insomnia
Interventions: Computerized Plasticity-Based Adaptive Cognitive Training, Commercially available computerized training; Other
Lead sponsor: Posit Science Corporation; Industry
Eligibility: 55 Years to 80 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Restless Legs Syndrome
Interventions: Noctrix Health NPNS device v1.0 - Active, Noctrix Health NPNS device v1.0 - Sham; Device
Lead sponsor: Noctrix Health, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 3
States / cities: Downey, California • Menlo Park, California • San Ramon, California

Conditions: Advanced Malignant Solid Neoplasm, Delirium, Hematopoietic and Lymphatic System Neoplasm, Insomnia
Interventions: Best Practice, Electronic Health Record Review, Interview, Questionnaire Administration, Suvorexant; Other · Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: ADHD, Sleep Problems
Interventions: Ferrous Sulfate, Placebo; Dietary Supplement · Other
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 8 Years to 18 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obstructive Sleep Apnea
Interventions: Mask A (Oran Park Mask) then Mask B (Evora Mask), Mask B (Evora Mask) then Mask A (Oran Park Mask); Device
Lead sponsor: ResMed; Industry
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 2
States / cities: San Diego, California • St Louis, Missouri

Conditions: Sleep Disturbance
Interventions: Cannabidiol oral solution, Inert sesame seed oil; Drug
Lead sponsor: Mariana Cherner, PhD; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: San Diego, California

Conditions: Head and Neck Cancer, Obstructive Sleep Apnea
Interventions: Nerve stimulation using nerve stimulation device and sterile wire electrode.; Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Sleep Disturbance, Insomnia
Interventions: Transcranial Electrical Neuromodulation (TES); Device
Lead sponsor: Brain Electrophysiology Laboratory Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Spinal Cord Injury, Sleep-disordered Breathing, Spinal Cord Disease, Multiple Sclerosis
Interventions: Best practices PAP + patient Education +ongoing Support and Training, Sleep Education; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Stress, Psychological, Sleep, Inflammation, Cardiovascular Diseases
Interventions: Mindfulness-Based Stress Reduction (MBSR); Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 87 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Obstructive Sleep Apnea
Interventions: continuous positive airway pressure (CPAP); Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 21 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obstructive Sleep Apnea
Interventions: Inspire® UAS System; Device
Lead sponsor: Inspire Medical Systems, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 14
States / cities: Birmingham, Alabama • Los Angeles, California • Miami, Florida + 9 more

Conditions: Jet Lag
Interventions: Hydrocortisone, Melatonin, Placebo; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Insomnia, Insomnia Chronic
Interventions: Zolpidem tartrate; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 40 Years to 85 Years
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Sleep Apnea, Obstructive
Interventions: Positive Airway Pressure (PAP), Oral Appliance (OA); Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 4
States / cities: Redwood City, California • Boston, Massachusetts • Philadelphia, Pennsylvania + 1 more

Conditions: Obstructive Sleep Apnea
Interventions: No Intervention; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 30 Years to 75 Years
Enrollment: 388 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Insomnia
Interventions: Zolpidem; Drug
Lead sponsor: Roxane Laboratories; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Autism Spectrum Disorder, Insomnia
Interventions: Ferrous sulfate, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 2 Years to 10 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 3
States / cities: Aurora, Colorado • Rochester, New York • Nashville, Tennessee

Conditions: Breast Cancer, Depression, Fatigue, Sleep Disorders
Interventions: Yoga, Education; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Search by objective public record fields.

Automated Manual Lymphatic Drainage Therapy to Improve Glymphatic Function in OSA Patients

The Effect of a Combined Nature-based and Virtual Mindfulness Intervention on Perceived Stress in Healthcare Workers

Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome

Trial of AD113 and Atomoxetine in OSA Patients With Hypertension

SM-1 vs. an Active Comparator in A Model of Transient Insomnia

STATE Trial: SusTained Attention Training to Enhance Sleep

Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep

Oran Park Mask External Clinical Study (3) Marketing Claims Study

CBD for Sleep in People With HIV

Intraoperative Ansa Cervicalis Nerve (ACN) Stimulation

Closed Loop TES for Enhancing Slow Wave Sleep

Treatment of Sleep-disordered Breathing in Patients With SCI

Stress Reduction Training to Improve Sleep Quality, Stress Physiology & Cardiovascular Disease (CVD) Risk Markers

Autonomic Function in Obstructive Sleep Apnea

Inspire® Post-Approval Study / Protocol Number 2014-001

Effects of Hydrocortisone, Melatonin, and Placebo on Jet Lag

Partial Reinforcement II: Three Approaches to Maintenance Therapy for Chronic Insomnia

Comparative Outcomes Management With Electronic Data Technology (COMET) Study

Metabolomics of Obstructive Sleep Apnea

Bioequivalency Study of Zolpidem Tartrate Under Fasting Conditions

Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder

Yoga or Educational Wellness Class for Women With Stage I, Stage II, or Stage III Breast Cancer Undergoing Chemotherapy